| 标题 |
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal for ImmunoTherapy of Cancer 作者:Jason Chesney; Karl D Lewis; Harriet Kluger; Omid Hamid; Eric Whitman; et al 出版日期:2022-12-13 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)